DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo


3.52 -0.06 (-1.68%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

XOMA $3.52 -1.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.60
Previous Close $3.58
Daily Range $3.51 - $3.70
52-Week Range $2.92 - $5.95
Market Cap $414.7M
P/E Ratio -5.51
Dividend (Yield) $0.00 (0.0%)
Volume 2,029,922
Average Daily Volume 2,344,508
Current FY EPS -$0.65




Drug Makers

XOMA Limited (XOMA) Description

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases. Website:

News & Commentary Rss Feed

Why XOMA Corp. Shares Rocketed Higher

XOMA shareholders press the launch button after the company begins the (approximate) countdown to a major news event.

XOMA: Phase 3 EYEGUARD-B Trial Is Good News For Gevokizumab

XOMA Corp Looks Good: Stock Gains 7.8% in Session - Tale of the Tape

XOMA Stock Gains on Poisitive Phase 3 Study Results of Behcet's Disease Treatment

How 1 Sentence Caused XOMA Corp. Shares to Explode Higher

XOMA Corp. released its first-quarter earnings results after the closing bell last night, but it was a single sentence from management, not its actually quarterly results, that has investors so excited today.

Friday's ETF Movers: XBI, FM

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

XOMA'S (XOMA) CEO John Varian on Q1 2015 Results - Earnings Call Transcript

XOMA (XOMA) Q1 2015 Results - Earnings Call Webcast

See More XOMA News...

XOMA's Top Competitors

XOMA $3.52 (-1.68%)
Current stock: XOMA
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB